Literature DB >> 30310456

Viewpoint: Role of Mind-body Therapies in the Management of Cardiovascular Disorders.

Kavita Prasad1.   

Abstract

Cardiovascular disorders (CVD) are the leading cause of death across the globe. The estimated cost to the National Health Service and UK economy is £30 billion. These costs continue to escalate despite major advances in pharmacotherapy and devices, which, in part, is due to improved survival, but also greater resource utilisation per patient. Hence, there is a need to develop cost-effective adjunctive therapies beyond conventional strategies. Mind-body therapies- including mindfulness and meditation, emotional regulation, practicing 'heartfelt' emotions including gratitude and compassion- may be novel low-cost approaches to reduce morbidity and mortality in CVD.

Entities:  

Keywords:  Mental stress; cardiovascular disorders; mindfulness

Year:  2016        PMID: 30310456      PMCID: PMC6159445          DOI: 10.15420/ecr.2016:17:2

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN: 1758-3756


  46 in total

1.  Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease.

Authors:  Maura Paul-Labrador; Donna Polk; James H Dwyer; Ivan Velasquez; Sanford Nidich; Maxwell Rainforth; Robert Schneider; C Noel Bairey Merz
Journal:  Arch Intern Med       Date:  2006-06-12

Review 2.  Mindfulness-based stress reduction for stress management in healthy people: a review and meta-analysis.

Authors:  Alberto Chiesa; Alessandro Serretti
Journal:  J Altern Complement Med       Date:  2009-05       Impact factor: 2.579

3.  Stress Management and Resiliency Training (SMART) program among Department of Radiology faculty: a pilot randomized clinical trial.

Authors:  Amit Sood; Varun Sharma; Darrell R Schroeder; Brian Gorman
Journal:  Explore (NY)       Date:  2014-08-21       Impact factor: 1.775

Review 4.  Stress and cardiovascular disease.

Authors:  Andrew Steptoe; Mika Kivimäki
Journal:  Nat Rev Cardiol       Date:  2012-04-03       Impact factor: 32.419

5.  Stress reduction in the secondary prevention of cardiovascular disease: randomized, controlled trial of transcendental meditation and health education in Blacks.

Authors:  Robert H Schneider; Clarence E Grim; Maxwell V Rainforth; Theodore Kotchen; Sanford I Nidich; Carolyn Gaylord-King; John W Salerno; Jane Morley Kotchen; Charles N Alexander
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-11-13

6.  A randomized controlled trial of stress reduction in African Americans treated for hypertension for over one year.

Authors:  Robert H Schneider; Charles N Alexander; Frank Staggers; David W Orme-Johnson; Maxwell Rainforth; John W Salerno; William Sheppard; Amparo Castillo-Richmond; Vernon A Barnes; Sanford I Nidich
Journal:  Am J Hypertens       Date:  2005-01       Impact factor: 2.689

Review 7.  State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease.

Authors:  Beth E Cohen; Donald Edmondson; Ian M Kronish
Journal:  Am J Hypertens       Date:  2015-04-24       Impact factor: 2.689

Review 8.  Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction.

Authors:  Abhiram Prasad; Amir Lerman; Charanjit S Rihal
Journal:  Am Heart J       Date:  2008-01-31       Impact factor: 4.749

Review 9.  A systematic review of neurobiological and clinical features of mindfulness meditations.

Authors:  A Chiesa; A Serretti
Journal:  Psychol Med       Date:  2009-11-27       Impact factor: 7.723

10.  Cardiac sympathetic activity in stress-induced (Takotsubo) cardiomyopathy.

Authors:  Abhiram Prasad; Malini Madhavan; Panithaya Chareonthaitawee
Journal:  Nat Rev Cardiol       Date:  2009-06       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.